1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow 2-(2-(4-chlorophenyl)ethoxy)adenosine: new trials by email Literature Review of 2-(2-(4-chlorophenyl)ethoxy)adenosine trials Research Report on 2-(2-(4-chlorophenyl)ethoxy)adenosine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers MRE0094, Vehicle gel - Foot Ulcer, Diabetic, Diabetes Complications | Phase 2 | Terminated | Pfizer | 16 | 2006-06-01 | 2012-06-01 |
| Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers MRE0094 - Foot Ulcer, Diabetic, Diabetes Complications | Phase 2 | Completed | Pfizer | 322 | 2005-12-01 | 2012-06-01 |
Diabetes Complications (2) · Diabetic Foot (2) · Foot Ulcer (2) · digital ulcers (2)
Pfizer (2)
United States (2)